Baseline characteristics of the 3,096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial

Baseline characteristics of the 3,096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial

Background: The risk of recurrence following ischaemic stroke (IS) or transient ischaemic attack (TIA) is highest immediately after the event. Antiplatelet agents are effective in reducing the risk of recurrence and two agents are superior to one in the early phase after ictus. Design: The Triple...

Full description

Bibliographic Details
Main Authors: Bath, Philip M.W., Appleton, Jason P., Beridze, M., Christensen, Hanne, Dineen, Robert A., Duley, Lelia, England, Timothy J., Heptinstall, Stan, James, Marilyn, Krishnan, Kailash, Markus, H.S., Pocock, Stuart J., Ranta, A., Robinson, Thompson G., Flaherty, Katie, Scutt, Polly, Venables, G., Woodhouse, Lisa J., Sprigg, Nikola
Format: Article
Language:English
Published: SAGE 2017
Online Access:http://eprints.nottingham.ac.uk/38851/
http://eprints.nottingham.ac.uk/38851/
http://eprints.nottingham.ac.uk/38851/
http://eprints.nottingham.ac.uk/38851/8/1747493016677988.pdf

Internet

http://eprints.nottingham.ac.uk/38851/
http://eprints.nottingham.ac.uk/38851/
http://eprints.nottingham.ac.uk/38851/
http://eprints.nottingham.ac.uk/38851/8/1747493016677988.pdf

Similar Items